Table 2.
(1) Healing of erosive esophagitis |
(2) Maintenance of healing of erosive esophagitis |
(3) Symptomatic gastroesophageal reflux disease |
(4) Helicobacter pylori eradication in combination with antibiotics |
(5) Short-term treatment of active gastric ulcer |
(6) Short-term treatment of active duodenal ulcer |
(7) Maintenance of healed duodenal ulcer |
(8) Healing of NSAID-Associated gastric ulcer |
(9) Risk reduction of NSAID-associated gastric Ulcer |
(10) Risk reduction of upper gastrointestinal bleeding in critically Ill patients |
(11) Pathological hypersecretory conditions including Zollinger-Ellison syndrome |
Abbreviations: FDA, Food and Drug Administration; NSAID, non-steroidal anti-inflammatory drugs.